Thank you to the over 200 participants and speakers at our yearly event on January 31st!
Thank you to:
GUNILLA WESTERGREN-THORSSON, director WCMM at Lund University, who gave her perspectives on the national Wallenberg Centre effort.
PERNILLE LAERKEGAARD HANSEN, professor and head of department of Chronic Kidney Disease at IMED CVRM AstraZeneca, that shared her talk ”We begin with the end”.
HENRIC OLSSON, head of Target Science IMED RIA AstraZeneca, who shared his experiences from 20 years in drug development and respiratory dieases.
BO SÖDERPALM, professor at the Institute of Neuroscience and physiology and senior consultant at the Sahlgrenska University Hospital, who has been awarded a Swedish Research Council “Proof of Concept” grant, that presented his research "Exploiting brain dopamine systems for treatment of alcohol use disorder“.
And a special thanks to our newly recruited WCMTM fellows and group leaders:
ANETTA HÄRTLOVA SVITORKA
Anetta Svitorka Härtlova has been recruited from the Newcastle University, UK, to the Institute of Biomedicine, and her main research focus is on understanding the role and regulation of immune and inflammatory pathways in the context of ageing and age-related pathologies.
Her talk was entitled "Understanding molecular mechanisms of innate immunity in age-related pathologies"
Alesia Tietze has been recruited from the University of Technology in Darmstadt, Germany, to the Institute of Chemistry and Molecular Biology. Alesia's research interest lies in the area of medicinal chemistry with focus on the development of protease-stable peptide analogs derived from bioactive peptides.
The title of her talk was "Chemical synthesis of bioactive peptides & membrane-associated proteins: from drug discovery to bioinspired materials”
Volkan Sayin has been recruited from the New York University School of Medicine, USA, to the Institute of Clinical Sciences. Volkan’s research is focusing on uncovering genotype dependent therapeutic vulnerabilities in lung cancer and he has a longstanding interest in redox biology, metabolism and the role of antioxidants in tumor development.
Volkan presented “Targeting metabolic dependencies in subtypes of lung cancer”
MARTIN DALIN, our newest clinical recruitment to Wallenberg Centre, presented his clinical research program within the area of cancer entitled "Circulating tumor DNA in pediatric cancer”.